查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1347715

結核病診斷市場：2023-2028 年全球行業趨勢、佔有率、規模、成長、機遇和預測

Tuberculosis Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

市場概況：

2022年，全球結核病診斷市場規模達到24億美元。展望未來，IMARC Group預計到2028年市場規模將達到32億美元，2023-2028年年複合成長率（CAGR）為5.28%。

結核病 (TB) 是一種傳染性細菌性疾病，主要影響肺部（肺）以及身體其他部位（肺外）。感染可通過曼圖結核菌素皮試 (TST) 或結核血檢來診斷。根據受感染的器官，需要進行額外的測試來確認結核病。對於肺結核，需要進行胸部X光檢查以檢測胸部異常，並對患者的痰液進行抗酸染色和顯微鏡檢查。肺外結核可以通過 CT、MRI 或超音波掃描、內視鏡檢查、腹腔鏡檢查、尿液和血液檢查、活體組織切片和腰椎穿刺來診斷。

結核病診斷市場趨勢：

全球耐多藥（MDR）結核病患病率的不斷上升是推動市場成長的關鍵因素之一。耐多藥結核病是由對異煙肼和利福平耐藥的細菌引起的，異煙肼和利福平被認為是治療結核病最有效的抗菌藥物之一。此外，技術先進的即時護理（POC）診斷方法的出現也推動了市場的成長。與傳統使用的技術相比，核酸擴增測試 (NAAT) 和乾擾素伽馬釋放測定 (IGRA) 等先進的診斷方法更加準確、方便，並且可以提供及時的結果。此外，醫療保健基礎設施的顯著改善，以及大眾對各種診斷程序的認知不斷增強，是另一個促進成長的因素。其他因素，包括老年人口的增加、醫療保健支出的增加以及政府促進研發 (R&D) 活動的舉措和投資，預計將進一步推動市場發展。

本報告回答的關鍵問題：

  • 迄今為止，全球結核病診斷市場表現如何？未來幾年將如何表現？
  • 主要區域市場有哪些？
  • COVID-19 對全球結核病診斷市場有何影響？
  • 根據疾病階段，市場的細分是什麼？
  • 根據測試類型，市場的細分是什麼？
  • 基於最終用戶的市場細分是什麼？
  • 行業價值鏈的各個階段是什麼？
  • 該行業的關鍵促進因素和挑戰是什麼？
  • 全球結核病診斷市場的結構如何？誰是主要參與者？
  • 行業競爭程度如何？

目錄

第一章：前言

第 2 章：範圍和方法

  • 研究目的
  • 利益相關者
  • 數據源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球結核病診斷市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：按疾病階段分類的市場細分

  • 潛伏性結核病
    • 市場走向
    • 市場預測
  • 活動性結核病
    • 市場走向
    • 市場預測

第 7 章：按測試類型分類的市場

  • 射線照相測試
    • 市場走向
    • 市場預測
  • 實驗室測試
    • 市場走向
    • 主要類型
      • 塗片顯微鏡
      • 基於文化的測試
    • 市場預測
  • 核酸檢測
    • 市場走向
    • 市場預測
  • 細胞因子檢測試驗
    • 市場走向
    • 市場預測
  • 耐藥性測試
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：最終用戶的市場細分

  • 醫院和診所
    • 市場走向
    • 市場預測
  • 診斷和研究實驗室
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：按地區分類的市場細分

  • 北美
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太地區
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳大利亞
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格指標

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Alere Inc.
    • Becton Dickinson and Company
    • BioMerieux
    • Cepheid Inc.
    • Epistem Ltd.
    • Roche Holding AG
    • Hain Lifescience GmbH
    • Hologic Inc.
    • QIAGEN GmbH
    • Siemens
    • Thermo Fisher Scientific Inc.
Product Code: SR112023A2047

Market Overview:

The global tuberculosis diagnostics market size reached US$ 2.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.28% during 2023-2028.

Tuberculosis (TB) refers to an infectious bacterial disease that primarily affects the lungs (pulmonary), along with other parts of the body (extrapulmonary). The infection is diagnosed via a Mantoux tuberculin skin test (TST) or the TB blood test. Additional tests are required to confirm TB disease, depending on the infected organs. In the case of pulmonary TB, chest radiography is performed for detecting chest abnormalities, along with acid-fast staining and microscopic examination of the patient's sputum. Extrapulmonary TB can be diagnosed using CT, MRI or ultrasound scans, endoscopy, laparoscopy, urine and blood tests, biopsies, and lumbar punctures.

Tuberculosis Diagnostics Market Trends:

The increasing prevalence of multi-drug resistant (MDR) tuberculosis across the globe is one of the key factors driving the growth of the market. MDR tuberculosis is caused by bacteria that are resistant to isoniazid and rifampicin, which are considered to be among the most potent antimicrobial drugs for TB. Furthermore, the availability of technologically advanced Point-of-Care (POC) diagnostic methods is also providing a boost to the market growth. Advanced diagnostic methods, such as Nucleic acid amplification tests (NAATs) and Interferon-Gamma Release Assay (IGRA), are more accurate, convenient, and provide prompt results in comparison to the traditionally used techniques. Additionally, significant improvements in the healthcare infrastructure, along with the growing awareness among the masses about various diagnostic procedures, are acting as another growth-inducing factor. Other factors, including the rising geriatric population and increasing healthcare expenditure and government initiatives and investments to promote research and development (R&D) activities, are projected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global tuberculosis diagnostics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on disease stage, test type, and end-user.

Breakup by Disease Stage:

Latent TB

Active TB

Breakup by Test Type:

Radiographic Test

Laboratory Test

Smear Microscopy

Culture-based Test

Nucleic Acid Testing

Cytokine Detection Test

Drug Resistance Test

Others

Breakup by End-User:

Hospitals and Clinics

Diagnostics and Research Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Alere Inc., Becton Dickinson and Company, BioMerieux, Cepheid Inc., Epistem Ltd., Roche Holding AG, Hain Lifescience GmbH, Hologic Inc., QIAGEN GmbH, Siemens, Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report:

  • How has the global tuberculosis diagnostics market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global tuberculosis diagnostics market?
  • What is the breakup of the market based on the disease stage?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global tuberculosis diagnostics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Tuberculosis Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Disease Stage

  • 6.1 Latent TB
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Active TB
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Test Type

  • 7.1 Radiographic Test
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Laboratory Test
    • 7.2.1 Market Trends
    • 7.2.2 Major Types
      • 7.2.2.1 Smear Microscopy
      • 7.2.2.2 Culture-based Test
    • 7.2.3 Market Forecast
  • 7.3 Nucleic Acid Testing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cytokine Detection Test
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Drug Resistance Test
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End-User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostics and Research Laboratories
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Alere Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Becton Dickinson and Company
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 BioMerieux
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Cepheid Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 Epistem Ltd.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Roche Holding AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Hain Lifescience GmbH
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Hologic Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 QIAGEN GmbH
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Siemens
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Thermo Fisher Scientific Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Tuberculosis Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Tuberculosis Diagnostics Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Tuberculosis Diagnostics Market: Breakup by Disease Stage (in %), 2022
  • Figure 4: Global: Tuberculosis Diagnostics Market: Breakup by Test Type (in %), 2022
  • Figure 5: Global: Tuberculosis Diagnostics Market: Breakup by End-User (in %), 2022
  • Figure 6: Global: Tuberculosis Diagnostics Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Tuberculosis Diagnostics Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 8: Global: Tuberculosis Diagnostics (Latent TB) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Tuberculosis Diagnostics (Latent TB) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Tuberculosis Diagnostics (Active TB) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Tuberculosis Diagnostics (Active TB) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Tuberculosis Diagnostics (Radiographic Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Tuberculosis Diagnostics (Radiographic Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Tuberculosis Diagnostics (Laboratory Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Tuberculosis Diagnostics (Laboratory Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Tuberculosis Diagnostics (Nucleic Acid Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Tuberculosis Diagnostics (Nucleic Acid Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Tuberculosis Diagnostics (Cytokine Detection Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Tuberculosis Diagnostics (Cytokine Detection Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Tuberculosis Diagnostics (Drug Resistance Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Tuberculosis Diagnostics (Drug Resistance Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Tuberculosis Diagnostics (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Tuberculosis Diagnostics (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Tuberculosis Diagnostics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Tuberculosis Diagnostics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Tuberculosis Diagnostics (Diagnostics and Research Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Tuberculosis Diagnostics (Diagnostics and Research Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Tuberculosis Diagnostics (Other End-Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Tuberculosis Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: North America: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: North America: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: United States: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: United States: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Canada: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Canada: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Asia Pacific: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Asia Pacific: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: China: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: China: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Japan: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Japan: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: India: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: India: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: South Korea: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: South Korea: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Australia: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Australia: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Indonesia: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Indonesia: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Others: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Others: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Europe: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Europe: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Germany: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Germany: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: France: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: France: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: United Kingdom: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: United Kingdom: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Italy: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Italy: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Spain: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Spain: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Russia: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Russia: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Others: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Others: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Latin America: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Latin America: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Brazil: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Brazil: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Mexico: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Mexico: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Others: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Others: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Middle East and Africa: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Middle East and Africa: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Global: Tuberculosis Diagnostics Industry: SWOT Analysis
  • Figure 79: Global: Tuberculosis Diagnostics Industry: Value Chain Analysis
  • Figure 80: Global: Tuberculosis Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Tuberculosis Diagnostics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Tuberculosis Diagnostics Market Forecast: Breakup by Disease Stage (in Million US$), 2023-2028
  • Table 3: Global: Tuberculosis Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
  • Table 4: Global: Tuberculosis Diagnostics Market Forecast: Breakup by End-User (in Million US$), 2023-2028
  • Table 5: Global: Tuberculosis Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Tuberculosis Diagnostics Market: Competitive Structure
  • Table 7: Global: Tuberculosis Diagnostics Market: Key Players